bioAffinity Technologies, Inc.
BIAF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,040 | -$7,937 | -$8,154 | -$6,326 |
| Dep. & Amort. | $606 | $250 | $10 | $5 |
| Deferred Tax | $0 | $0 | $0 | $3,841 |
| Stock-Based Comp. | $990 | $749 | $249 | $43 |
| Change in WC | $180 | $901 | $114 | $633 |
| Other Non-Cash | $0 | $0 | $3,710 | -$244 |
| Operating Cash Flow | -$7,265 | -$6,038 | -$4,071 | -$2,049 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$79 | -$23 | -$220 | $0 |
| Net Acquisitions | $0 | -$2,186 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$79 | -$2,209 | -$220 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$169 | -$345 | $584 | $212 |
| Stock Issued | $4,351 | $0 | $6,027 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,446 | $0 | $7,732 | $3,114 |
| Financing Cash Flow | $5,628 | -$345 | $14,344 | $3,327 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,716 | -$8,592 | $10,053 | $1,278 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,822 | $11,414 | $1,361 | $83 |
| End Cash | $1,105 | $2,822 | $11,414 | $1,361 |
| Free Cash Flow | -$7,344 | -$6,061 | -$4,291 | -$2,049 |